---

---

tags : Disease    symbols : Vtrs   

save search

---

Theravance Biopharma Announces Results from the Phase 4 YUPELRI® PIFR-2 Study in Patients with Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Published: 2024-01-05 (Crawled : 11:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -3.72% | O: 0.0% H: 4.59% C: 3.72%
TBPH | $9.22 -3.15% -3.25% 360K |

Health Technology

| -17.36% | O: -11.02% H: 6.05% C: 1.17%
yupelri disease biopharma results study

---

Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published: 2023-12-01 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
BHC | $8.6 -0.69% 0.0% 2.1M |

Health Technology

| Email alert Add to watchlist
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| Email alert Add to watchlist
BCLI | $0.503 -6.99% -7.51% 1.1M |

Health Technology

| Email alert Add to watchlist
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| Email alert Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| Email alert Add to watchlist
disease companies health therapeutics market

---

Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -11.93% | O: -18.18% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -1.63% | O: -3.68% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 23.69% | O: 0.0% H: 0.17% C: -2.45%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -1.29% | O: -0.23% H: 0.08% C: -1.92%
BHC | $8.6 -0.69% 0.0% 2.1M |

Health Technology

| 29.87% | O: -0.59% H: 0.15% C: -1.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -14.36% | O: -15.73% H: 0.0% C: 0.0%
BCLI | $0.503 -6.99% -7.51% 1.1M |

Health Technology

| 216.77% | O: 3.73% H: 1.8% C: -4.19%
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| -19.05% | O: -0.45% H: 0.12% C: -2.28%
propel disease research therapeutics growth market

---

Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published: 2023-08-16 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 19.81% | O: 5.46% H: 0.0% C: -2.87%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 8.37% | O: -0.67% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -0.36% | O: -0.99% H: 1.45% C: 1.36%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -9.27% | O: -0.2% H: 0.34% C: -0.26%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 12.31% | O: -0.77% H: 0.79% C: 0.17%
BAX | $39.65 0.33% 0.0% 2.3M |

Health Technology

| -6.26% | O: -0.4% H: 0.73% C: -0.24%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 8.92% | O: 0.56% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| 0.48% | O: -1.36% H: 0.88% C: 0.07%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -14.49% | O: -1.33% H: 0.0% C: 0.0%
disease market

---

Alzheimer's disease therapeutics market size to increase by USD 3.99 billion; North America to account for 37% of market growth - Technavio
Published: 2023-02-08 (Crawled : 01:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -6.71% | O: 0.5% H: 0.17% C: -2.17%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 7.12% | O: 0.87% H: 0.17% C: -1.53%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 14.21% | O: 2.69% H: 3.5% C: 0.13%
DNLI | $16.6 -1.31% -1.33% 1.2M |

Health Technology

| -43.13% | O: 0.79% H: 0.55% C: -2.28%
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| -31.63% | O: 0.23% H: 2.12% C: 0.31%
america disease alzheimer's therapeutics growth market

---

Non-steroidal Anti-inflammatory Drugs Market Research Report by Disease Indication, Drugs, Route of Administration, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-07 (Crawled : 16:00) - prnewswire.com
RBGPF | $52.0 6.46% 34K |

Consumer Non-Durables

| -26.52% | O: 0.06% H: 3.15% C: 0.15%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 7.16% | O: 0.74% H: 0.0% C: -6.74%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -4.51% | O: 1.62% H: 0.0% C: -4.28%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| -1.06% | O: -0.56% H: 0.61% C: 0.01%
RBGLY | $10.29 -2.05% 1.4M |

Manufacturing

| -29.45% | O: 0.51% H: 0.48% C: -0.14%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 1.74% | O: 0.0% H: 0.55% C: -0.27%
ZTS | News | $153.11 1.05% 0.48% 4.8M |

Health Technology

| -1.08% | O: -0.06% H: 0.54% C: -1.77%
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -5.33% | O: -0.09% H: 0.47% C: -0.28%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 4.43% | O: -0.98% H: 0.24% C: -1.78%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 103.71% | O: 0.21% H: 1.6% C: 0.72%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| 0.86% | O: 5.18% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| -0.43% | O: 0.45% H: 0.64% C: -0.03%
covid-19 research global disease report impact distribution market

---

Parkinson's Disease Drugs Market to Reach $10.4 Bn, Globally, by 2031 at 6.2% CAGR: Allied Market Research
Published: 2022-11-17 (Crawled : 12:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 24.31% | O: 0.98% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 0.36% | O: -1.62% H: 1.01% C: 0.55%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 11.41% | O: -1.56% H: 1.64% C: 1.47%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 20.33% | O: -2.04% H: 1.21% C: 1.09%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 8.75% | O: -0.59% H: 1.39% C: 0.79%
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| -34.95% | O: -0.98% H: 1.97% C: 1.68%
research disease parkinson's market

---

USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published: 2022-09-29 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 33.95% | O: -3.32% H: 4.73% C: 4.73%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 51.07% | O: 1.87% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 27.38% | O: -1.26% H: 0.7% C: -0.23%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 21.96% | O: 0.17% H: 1.1% C: 0.16%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 34.42% | O: -0.14% H: 0.53% C: -0.2%
BHC | $8.6 -0.69% 0.0% 2.1M |

Health Technology

| 17.0% | O: -1.2% H: 0.0% C: -5.83%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 14.22% | O: 0.17% H: 0.28% C: -1.47%
disease expected dermatological growth market

---

Alzheimer's Disease Therapeutics Market to record USD 3.99 Bn growth -- Driven by the availability, research, and development of novel biomarkers
Published: 2022-09-28 (Crawled : 09:00) - prnewswire.com
GIKLY | $4.6 132.75% 4.5K |

Manufacturing

| -6.31% | O: -6.72% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 53.92% | O: 1.89% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 31.13% | O: 0.94% H: 2.22% C: 1.99%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 24.69% | O: 1.46% H: 1.25% C: 0.77%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 16.54% | O: 1.76% H: 0.76% C: 0.26%
DNLI | $16.6 -1.31% -1.33% 1.2M |

Health Technology

| -36.46% | O: 6.45% H: 16.46% C: 10.57%
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| -1.33% | O: 43.06% H: 0.17% C: -2.24%
disease alzheimer's therapeutics biomarkers growth market

---

Alzheimer's Disease Therapeutics Market 2022-2026 | Availability, Research, and Development of Novel Biomarkers to Boost Growth | Technavio
Published: 2022-04-26 (Crawled : 10:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 9.61% | O: 1.72% H: 1.7% C: -0.29%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 3.61% | O: 0.47% H: 0.83% C: -1.44%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 7.18% | O: 1.32% H: 0.0% C: 0.0%
DNLI | $16.6 -1.31% -1.33% 1.2M |

Health Technology

| -35.59% | O: -0.59% H: 1.72% C: -7.7%
BIIB | $190.55 -0.84% -0.84% 1.5M |

Health Technology

| -6.76% | O: 1.77% H: 0.71% C: -2.82%
disease alzheimer's therapeutics growth market alzheimer’s biomarkers

---

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K |

Health Technology

| -39.47% | O: -2.78% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -26.31% | O: -0.99% H: 0.0% C: -0.11%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -15.25% | O: 0.27% H: 0.0% C: 0.0%
MNKKQ | $0.02 |

Manufacturing

| -81.52% | O: -2.96% H: 2.29% C: -6.57%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -41.26% | O: -0.1% H: 0.35% C: -0.09%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 4.12% | O: -5.01% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 2.91% | O: -0.67% H: 0.0% C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -20.61% | O: 0.01% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -12.45% | O: -1.57% H: 1.5% C: 1.39%
BSX | $67.42 -0.8% -0.53% 5.9M |

Health Technology

| 46.44% | O: -4.95% H: 2.32% C: 1.9%
BHC | $8.6 -0.69% 0.0% 2.1M |

Health Technology

| -60.51% | O: -3.12% H: 0.37% C: 0.19%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 4.85% | O: -2.17% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -17.48% | O: -2.01% H: 0.0% C: 0.0%
NMRD | $0.1053 -28.78% 820K |

Health Technology

| -97.57% | O: 17.02% H: 0.52% C: -2.6%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| 4.09% | O: -1.38% H: 0.65% C: 0.46%
device disease

---

Insights on the Liver Disease Treatment Global Market to 2027 - by Treatment Type, Disease Type, End-user and Region
Published: 2022-04-12 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -28.97% | O: 1.76% H: 0.35% C: 0.35%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -19.39% | O: 0.15% H: 0.0% C: -4.71%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 22.54% | O: 0.45% H: 0.0% C: -0.83%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -41.99% | O: 2.3% H: 0.55% C: 0.36%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| 4.22% | O: 0.37% H: 2.99% C: 2.61%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -10.91% | O: -0.2% H: 1.83% C: 1.83%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| 0.44% | O: 0.12% H: 0.44% C: 0.17%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -15.35% | O: -0.24% H: 0.45% C: 0.39%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 143.69% | O: -0.26% H: 0.33% C: -1.5%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -36.9% | O: 0.24% H: 0.53% C: 0.18%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -1.29% | O: -1.38% H: 0.0% C: -3.67%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -10.13% | O: -0.7% H: 1.91% C: 1.63%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -18.73% | O: 0.77% H: 0.0% C: 0.0%
treatment liver disease market

---

Injectable Drug Delivery Devices Market size to increase by USD 22.29 Bn | Rising prevalence of chronic diseases to accelerate growth | Technavio
Published: 2022-02-22 (Crawled : 04:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -8.74% | O: 1.59% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 14.68% | O: 1.71% H: 2.6% C: 0.25%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -24.41% | O: -1.02% H: 1.2% C: -0.07%
BAX | $39.65 0.33% 0.0% 2.3M |

Health Technology

| -51.79% | O: 0.18% H: 2.74% C: 2.38%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -13.31% | O: -1.26% H: 0.81% C: 0.46%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 14.04% | O: 3.24% H: 0.18% C: -1.6%
drug device liver disease cel growth drug delivery

---

Viatris is First to Receive FDA Approval of Generic Restasis® (Cyclosporine Ophthalmic Emulsion 0.05%) to Treat Dry Eye Disease
Published: 2022-02-03 (Crawled : 23:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -26.89% | O: -1.05% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -12.63% | O: -2.48% H: 0.0% C: 0.0%
restasis dry eye fda eye fda approval eye disease approval disease ophthalmic emulsion

---

Worldwide Budesonide Inhaler Industry to 2026 - Further Innovation in Inhaled Therapy for Airways Disease Presents Opportunities
Published: 2021-09-30 (Crawled : 18:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 11.27% | O: -1.61% H: 0.07% C: -1.56%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -17.93% | O: 0.07% H: 1.22% C: 0.29%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -19.72% | O: -0.15% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -9.93% | O: 0.06% H: 0.19% C: -0.84%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 13.66% | O: -1.28% H: 0.0% C: 0.0%
disease therapy

---

Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Published: 2021-09-15 (Crawled : 12:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -18.71% | O: -0.44% H: 1.17% C: 0.81%
TBPH | $9.22 -3.15% -3.25% 360K |

Health Technology

| 18.41% | O: -19.15% H: 15.54% C: 4.15%
INVA | $14.69 1.45% 1.43% 640K |

Health Technology

| -3.98% | O: 0.2% H: 0.4% C: -0.53%
disease biopharma respiratory

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---